Does the consumption of soya products affect cholesterol levels, blood pressure, or other cardiovascular health indicators?
DOI:
https://doi.org/10.12775/QS.2025.38.58171Keywords
Soy, Soy products, Isoflavones, Hypertension, Lipid profile, CVD, LDLAbstract
Introduction and Purpose
Cardiovascular diseases (CVD) are the leading factor of mortality among people in the world. For this reason, people are trying to find factors that could improve the condition of the circulatory system. Soy is one of the most popular products in Asian cuisine. Its consumption is increasing due to a strong interest in vegetarian cuisine, in which soy is an important element. As its popularity grows, more and more research is being done to see if it has cardiovascular disease-preventing properties.
Aim of the study
This study aims to analyse the current state of knowledge regarding the effect of soy consumption on: hypertension, lipid profile, biomarkers of inflammation, vascular epithelium and impact on mortality caused by cardiovascular diseases.
Material and methods
For this review, we analyzed articles that we found in Pubmed and Google Scholar and that were related to our topic.
Conclusion
Many studies have shown a beneficial effect of soy products on lipid profile, especially in lowering LDL-C levels. Soy consumption may have an impact on modulating inflammatory markers, but further research is needed. Researchers have shown that soy may have a role in lowering blood pressure, especially in people with hypertension or an increased risk of CVD. Soy can be a part of our daily, healthy diet, but its impact on all-cause mortality and CVD depends on many factors such as people's age, comorbidity, dietary context and type of consumed soy ( e.g. fermented or not fermented).
References
Di Cesare M, Perel P, Taylor S, et al. The Heart of the World. Glob Heart. 2024;19(1):11. Published 2024 Jan 25. https://doi.org/10.5334/gh.1288
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in Circulation. 2019 Sep 10;140(11):e649-e650. https://doi.org/10.1161/CIR.0000000000000678
Rizzo G, Baroni L. Soy, Soy Foods and Their Role in Vegetarian Diets. Nutrients. 2018;10(1):43. Published 2018 Jan 5. https://doi.org/10.3390/nu10010043
“Insights on European uptake of certified, responsible, deforestation and conversion-free soy in 2021.” IDH - the Sustainable Trade Initiative, https://www.idhsustainabletrade.com/uploaded/2023/09/IDH-Soy-Monitor-2021-Final.pdf. Accessed 17 November 2024.
Torres N, Torre-Villalvazo I, Tovar AR. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem. 2006;17(6):365-373. https://doi.org/10.1016/j.jnutbio.2005.11.005 Accessed 17 November 2024
Ko KP. Isoflavones: chemistry, analysis, functions and effects on health and cancer. Asian Pac J Cancer Prev. 2014;15(17):7001-7010. https://doi.org/10.7314/APJCP.2014.15.17.7001
Tokede OA, Onabanjo TA, Yansane A, Gaziano JM, Djoussé L. Soya products and serum lipids: a meta-analysis of randomised controlled trials. Br J Nutr. 2015;114(6):831-843. https://doi.org/10.1017/S0007114515002603
Namazi N , Saneei P , Larijani B , Esmaillzadeh A . Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies. Food Funct. 2018;9(5):2576-2588. DOI: https://doi.org/10.1039/C7FO01622K
Du H, Shi Q, Song P, et al. Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019. Front Cardiovasc Med. 2022;9:903126. Published 2022 Jun 9. https://doi.org/10.3389/fcvm.2022.903126
Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem. 2005;16(6):321-330. https://doi.org/10.1016/j.jnutbio.2004.11.008
Qin Y, Shu F, Zeng Y, et al. Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI. J Nutr. 2014;144(1):49-54. https://doi.org/10.3945/jn.113.182725
Liu ZM, Ho SC, Chen YM, et al. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. Mol Nutr Food Res. 2014;58(4):709-717. https://doi.org/10.1002/mnfr.201300499
Jung SM, Haddad EH, Kaur A, et al. A Non-Probiotic Fermented Soy Product Reduces Total and LDL Cholesterol: A Randomized Controlled Crossover Trial. Nutrients. 2021;13(2):535. Published 2021 Feb 6. https://doi.org/10.3390/nu13020535
Yu D, Zhang X, Xiang YB, et al. Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. Int J Cardiol. 2014;172(2):e285-e287. https://doi.org/10.1016/j.ijcard.2013.12.200
Zeng Q, Xu T, Luo Z, et al. Effect of inflammatory factors on myocardial infarction. BMC Cardiovasc Disord. 2024;24(1):538. Published 2024 Oct 7.
https://doi.org/10.1186/s12872-024-04122-4
Gupta L, Thomas J, Ravichandran R, Singh M, Nag A, Panjiyar BK. Inflammation in Cardiovascular Disease: A Comprehensive Review of Biomarkers and Therapeutic Targets. Cureus. 2023;15(9):e45483. Published 2023 Sep 18. https://doi.org/10.7759/cureus.45483
Stavros Apostolakis, Konstantina Vogiatzi, Virginia Amanatidou, Demetrios A. Spandidos, Interleukin 8 and cardiovascular disease, Cardiovascular Research, Volume 84, Issue 3, 1 December 2009, Pages 353–360, https://doi.org/10.1093/cvr/cvp241
Hao Wu, Tingzi Hu, Hong Hao, Michael A Hill, Canxia Xu, Zhenguo Liu, Inflammatory bowel disease and cardiovascular diseases: a concise review, European Heart Journal Open, Volume 2, Issue 1, January 2022, oeab029, https://doi.org/10.1093/ehjopen/oeab029
Reverri EJ, LaSalle CD, Franke AA, Steinberg FM. Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk. Mol Nutr Food Res. 2015;59(2):323-333. https://doi.org/10.1002/mnfr.201400270
Rebholz CM, Reynolds K, Wofford MR, et al. Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. Eur J Clin Nutr. 2013;67(1):58-63. https://doi.org/10.1038/ejcn.2012.186
Nadadur M, Stanczyk FZ, Tseng CC, Kim L, Wu AH. The Effect of Reduced Dietary Fat and Soy Supplementation on Circulating Adipocytokines in Postmenopausal Women: A Randomized Controlled 2-Month Trial. Nutr Cancer. 2016;68(4):554-559. https://doi.org/10.1080/01635581.2016.1158294
Prokopidis K, Mazidi M, Sankaranarayanan R, Tajik B, McArdle A, Isanejad M. Effects of whey and soy protein supplementation on inflammatory cytokines in older adults: a systematic review and meta-analysis. Br J Nutr. 2023;129(5):759-770. https://doi.org/10.1017/S0007114522001787
Mileva N, Velikova T, Velikov T, Vassilev D. Aortic Elasticity and Cardiovascular Risk Stratification: A Narrative Review on the Current Understanding. J. Vasc. Dis. 2024, 3, 88-101. https://doi.org/10.3390/jvd3010008
Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly?. Age Ageing. 2007;36(1):43-48. https://doi.org/10.1093/ageing/afl115
De Caterina R, Ghiadoni L, Taddei S, et al. Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. Am J Hypertens. 2001;14(3):259-266. https://doi.org/10.1016/S0895-7061(00)01276-0
Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force [published correction appears in J Am Coll Cardiol 2002 Mar 20;39(6):1082]. J Am Coll Cardiol. 2002;39(2):257-265. doi:10.1016/s0735-1097(01)01746-6
https://doi.org/10.1016/S0735-1097(01)01746-6
Tischmann L, Adam TC, Mensink RP, Joris PJ. Longer-term soy nut consumption improves vascular function and cardiometabolic risk markers in older adults: Results of a randomized, controlled cross-over trial. Clin Nutr. 2022;41(5):1052-1058. https://doi.org/10.1016/j.clnu.2022.03.014
Beavers DP, Beavers KM, Miller M, Stamey J, Messina MJ. Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2012;22(3):182-191. https://doi.org/10.1016/j.numecd.2010.05.007.
“Hypertension.” World Health Organization (WHO), 16 March 2023, https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed 26 November 2024.
Mohammadifard N, Salehi-Abargouei A, Salas-Salvadó J, Guasch-Ferré M, Humphries K, Sarrafzadegan N. The effect of tree nut, peanut, and soy nut consumption on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials. Am J Clin Nutr. 2015;101(5):966-982.
https://doi.org/10.3945/ajcn.114.091595
Movahedian M, Tabibi H, Atabak S, Hedayati M, Rahmani L, Yari Z. Effects of Soy Isoflavones on Glycemic Parameters and Blood Pressure in Peritoneal Dialysis Patients: A Randomized, Double Blind, Placebo-Controlled Trial. Iran J Kidney Dis. 2021;1(2):134-142. https://doi.org/10.1016/j.numecd.2020.04.023
Mosallanezhad Z, Mahmoodi M, Ranjbar S, et al. Soy intake is associated with lowering blood pressure in adults: A systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Complement Ther Med.
https://doi.org/10.1016/j.ctim.2021.102692
Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015;64(2):236-243. https://doi.org/10.1016/j.metabol.2014.09.005
Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004;12(6):1559-1567. https://doi.org/10.1016/j.bmc.2003.11.035
Shah RD, Tang ZZ, Chen G, Huang S, Ferguson JF. Soy food intake associates with changes in the metabolome and reduced blood pressure in a gut microbiota dependent manner. Nutr Metab Cardiovasc Dis. 2020;30(9):1500-1511. https://doi.org/10.1016/j.numecd.2020.05.001
Ying Zhang,Brian W. Spitzer,Yu Zhang,Danielle A. Wallace,Bing Yu,Qibin Qi,Maria Argos,M Larissa Avilés-Santa,Eric Boerwinkle,Martha L. Daviglus,Robert Kaplan,Jianwen Cai,Susan Redline,Tamar Sofer,Untargeted metabolome atlas for sleep-related phenotypes in the Hispanic community health study/study of Latinos, eBioMedicine, 111, (105507), (2025). https://doi.org/10.1016/j.ebiom.2024.105507
Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT. Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):463-70. doi: 10.1016/j.numecd.2010.09.006. https://doi.org/10.1016/j.numecd.2010.09.006
Lei L, Hui S, Chen Y, Yan H, Yang J, Tong S. Effect of soy isoflavone supplementation on blood pressure: a meta-analysis of randomized controlled trials [published correction appears in Nutr J. 2024 May 17;23(1):53. https://doi.org/10.1186/s12937-024-00932-6
Yu D, Shu XO, Li H, et al. Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women. Am J Clin Nutr. 2015;102(3):680-686.
https://doi.org/10.3945/ajcn.115.111591
Urano T, Ihara H, Umemura K, et al. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis Cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem. 2001;276(27):24690-24696. https://doi.org/10.1074/jbc.M101751200
Nagata C, Wada K, Tamura T, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr. 2017;105(2):426-431.
https://doi.org/10.3945/ajcn.116.137281
Guo J, Li W, Wang Y, et al. Influence of dietary patterns on the risk of acute myocardial infarction in China population: the INTERHEART China study. Chin Med J (Engl). 2013;126(3):464-470. PMID: 23422108.
Zamora-Ros R, Jiménez C, Cleries R, et al. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology. 2013;24(5):726-733. https://doi.org/10.1097/EDE.0b013e31829d5902
Ivey KL, Hodgson JM, Croft KD, Lewis JR, Prince RL. Flavonoid intake and all-cause mortality. Am J Clin Nutr. 2015;101(5):1012-1020.
https://doi.org/10.3945/ajcn.113.073106
Talaei M, Koh WP, van Dam RM, Yuan JM, Pan A. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr. 2014;144(6):921-928. https://doi.org/10.3945/jn.114.190454
Yamasaki K, Kayaba K, Ishikawa S. Soy and Soy Products Intake, All-Cause Mortality, and Cause-Specific Mortality in Japan: The Jichi Medical School Cohort Study. Asia Pac J Public Health. 2015;27(5):531-541.
https://doi.org/10.1177/1010539514539545
Namazi N, Saneei P, Larijani B, Esmaillzadeh A . Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies. Food Funct. 2018;9(5):2576-2588.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aleksandra Walendzik, Kinga Racisz, Joanna Duda, Jakub Kędzia, Alicja Obcowska, Paweł Racisz, Łukasz Sencerek

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 158
Number of citations: 0